Episode 358: The Quest for Immortality: Inside Gero's Mission to Slow Down Human Aging and Extend Lifespan
Have you ever wondered if science could potentially double the human lifespan? That's the moonshot biotech company Gero is chasing. Led by physicist-turned-CEO and Co-Founder Peter Fedichev, Gero harnesses the mind-bending mix of physics, AI, and good old biology to develop therapeutics against chronic diseases and slow down human aging itself. They're not just throwing darts—Gero is developing mRNA vaccines, similar to those used for COVID-19, to fight aging. With partnerships with industry giants like Pfizer, Gero is on the cusp of revolutionizing longevity. Interested in living a longer, healthier life? This is your chance to be a part of something truly groundbreaking— visit Gero’s website today: https://gero.ai/ Watch the full YouTube interview here: https://youtu.be/j0vFRkN1Lx8 And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
You May Also Like

Equity Mates Investing Podcast
Equity Mates Media

Inversión Dividendos
Carlos García

Datasets
Visionary

🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen

Marketplace All-in-One
Marketplace

Stock Movers
iHeartPodcasts

The Wolf Of All Streets
Scott Melker

The Lucy Ann Lance Show
Cumulus Media Detroit

CNBC Business News Update
CNBC

Innovation Fuel: Real-World Business Cases
Gelareh Farhadian and Dave Keighron
Community discussion